Latest News
Latest News
SUNSHINE BIOPHARMA BELIEVES THAT AN EFFECTIVE CORONAVIRUS TREATMENT CONTINUES TO BE NECESSARY
For Immediate Release November 24, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and…
Sunshine Biopharma Signs an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it…
Sunshine Biopharma Signs an Agreement for Distribution of Essential-9TM in Asia and the Far East
For Immediate Release November 10, 2020 Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Pink: “SBFM”) today announced that it has signed an agreement with JOAH International Pte.,…
SUNSHINE BIOPHARMA RECEIVES SECOND TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT
For Immediate Release October 26, 2020 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology…
CEO of Sunshine Biopharma, Dr. Steve Slilaty, is Featured on The Stock Day Podcast
Phoenix, October 22nd, 2020 (Newsfile Corp.) — The Stock Day Podcast welcomed Sunshine Biopharma (SBFM) (“the Company”), a company working on the development of a treatment for COVID-19, as well…
SUNSHINE BIOPHARMA AND UNIVERSITY OF GEORGIA TEAM UP TO DEVELOP A NEW ANTI-CORONAVIRUS DRUG
For Immediate Release October 19, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and…
SUNSHINE BIOPHARMA IDENTIFIES A LEAD ANTI-CORONAVIRUS COMPOUND
For Immediate Release – October 7, 2020. Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), apharmaceutical company focused on the research, development and commercialization ofoncology and antiviral…
SUNSHINE BIOPHARMA SECURES $2,000,000 FINANCING FOR CORONAVIRUS TREATMENT
For Immediate Release – September 15, 2020. Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC Markets:“SBFM”), a pharmaceutical company focused on the research, development andcommercialization of oncology and…
SUNSHINE BIOPHARMA COMPLETES THE SYNTHESIS OF FOUR POTENTIAL INHIBITORS OF CORONAVIRUS PROTEASE
For Immediate Release, August 25, 2020. Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), apharmaceutical company focused on the research, development and commercialization ofoncology and antiviral drugs…
